133 related articles for article (PubMed ID: 27139114)
1. Non-18F-FDG PET/CT in the management of patients affected by HNC: state-of-the-art.
Quartuccio N; Caobelli F; Di Mauro F; Cammaroto G;
Nucl Med Commun; 2016 Sep; 37(9):891-8. PubMed ID: 27139114
[TBL] [Abstract][Full Text] [Related]
2. Atypical
Childs L; Thompson A; Jones H; Hameeduddin A; Ghufoor K; Adams A
Clin Imaging; 2018; 49():136-143. PubMed ID: 29414508
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
Al-Bulushi NK; Abouzied ME
Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
[TBL] [Abstract][Full Text] [Related]
4. Emerging Opportunities for Digital PET/CT to Advance Locoregional Therapy in Head and Neck Cancer.
Wright CL; Washington IR; Bhatt AD; Knopp MV
Semin Radiat Oncol; 2019 Apr; 29(2):93-101. PubMed ID: 30827458
[TBL] [Abstract][Full Text] [Related]
5. Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [
Crispin-Ortuzar M; Apte A; Grkovski M; Oh JH; Lee NY; Schöder H; Humm JL; Deasy JO
Radiother Oncol; 2018 Apr; 127(1):36-42. PubMed ID: 29273260
[TBL] [Abstract][Full Text] [Related]
6. [PET-CT in head and neck cancer].
Send T; Kreppel B; Gaertner FC; Bundschuh RA; Strunk H; Bootz F; Essler M
HNO; 2017 Jun; 65(6):504-513. PubMed ID: 28451717
[TBL] [Abstract][Full Text] [Related]
7. The potential role of non-FDG-PET in the management of head and neck cancer.
Heuveling DA; de Bree R; van Dongen GA
Oral Oncol; 2011 Jan; 47(1):2-7. PubMed ID: 21109481
[TBL] [Abstract][Full Text] [Related]
8. PET Imaging for Head and Neck Cancers.
Marcus C; Sheikhbahaei S; Shivamurthy VKN; Avey G; Subramaniam RM
Radiol Clin North Am; 2021 Sep; 59(5):773-788. PubMed ID: 34392918
[TBL] [Abstract][Full Text] [Related]
9. FDG PET in head and neck cancer.
Keyes JW; Watson NE; Williams DW; Greven KM; McGuirt WF
AJR Am J Roentgenol; 1997 Dec; 169(6):1663-9. PubMed ID: 9393187
[TBL] [Abstract][Full Text] [Related]
10. New tracers beyond FDG in head and neck oncology.
Gornik G; Weber W
Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):529-40. PubMed ID: 22019710
[TBL] [Abstract][Full Text] [Related]
11.
Tsetsos N; Poutoglidis A; Arsos G; Tsentemeidou A; Kilmpasanis A; Katsampoukas D; Fyrmpas G
Am J Otolaryngol; 2022; 43(1):103209. PubMed ID: 34536919
[TBL] [Abstract][Full Text] [Related]
12. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
13. Advances in Functional Imaging in the Assessment of Head and Neck Cancer.
Wan DQ
Oral Maxillofac Surg Clin North Am; 2019 Nov; 31(4):627-635. PubMed ID: 31473063
[TBL] [Abstract][Full Text] [Related]
14. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.
Lee NY; Mechalakos JG; Nehmeh S; Lin Z; Squire OD; Cai S; Chan K; Zanzonico PB; Greco C; Ling CC; Humm JL; Schöder H
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):2-13. PubMed ID: 17869020
[TBL] [Abstract][Full Text] [Related]
15. Role of Non-FDG-PET/CT in Head and Neck Cancer.
Marcus C; Subramaniam RM
Semin Nucl Med; 2021 Jan; 51(1):68-78. PubMed ID: 33246541
[TBL] [Abstract][Full Text] [Related]
16. Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.
Thorwarth D; Eschmann SM; Holzner F; Paulsen F; Alber M
Radiother Oncol; 2006 Aug; 80(2):151-6. PubMed ID: 16920211
[TBL] [Abstract][Full Text] [Related]
17. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
[TBL] [Abstract][Full Text] [Related]
18. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
19. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
Lee HS; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443
[TBL] [Abstract][Full Text] [Related]
20. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake.
Blodgett TM; Fukui MB; Snyderman CH; Branstetter BF; McCook BM; Townsend DW; Meltzer CC
Radiographics; 2005; 25(4):897-912. PubMed ID: 16009814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
